Two new landmark studies show how a seeming tangle of DNA is actually organized into a structure that coordinates thousands ...

Dr. Lisa Ramaut from the Department of Plastic, Reconstructive, and Aesthetic Surgery at the Brussels University Hospital (UZ ...

Uday R. Popat, MD, discusses the rationale behind evaluating itacitinib over other JAK inhibitors for graft-vs-host disease prophylaxis in a phase 2 study.

Trumbull’s bill is aiming to tap into the significant potential of stem cell therapies in advancing medical treatments and ...

Cato T. Laurencin, MD, PhD, who is well-known as a scientist and entrepreneur with an extensive career in regenerative ...

The Food and Drug Administration (FDA) has granted Fast Track designation to BRTX-100 for the treatment of chronic lumbar disc disease, defined as back and/or radicular pain with confirmed ...

ADIA Nutrition Inc. (OTC Pink: ADIA), a trailblazer in healthcare innovation, proudly announces a major milestone for its new ...

Therapeutics announced positive preclinical data from CDX-622, a novel bispecific antibody that targets two non-redundant, ...

FDA has provided input on key elements of the SER-155 allo-HSCT clinical development plans including support for the proposed primary efficacy endpoint of reduction in bloodstream infections (BSIs) as ...

“Gene therapy for hemophilia A with the use of lentiviral vector-transduced autologous HSCs resulted in stable factor VIII expression, with factor VIII activity correlating to vector copy number in ...